H32_HUMAN - dbPTM
H32_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID H32_HUMAN
UniProt AC Q71DI3
Protein Name Histone H3.2
Gene Name HIST2H3A
Organism Homo sapiens (Human).
Sequence Length 136
Subcellular Localization Nucleus. Chromosome.
Protein Description Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling..
Protein Sequence MARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Asymmetric dimethylarginine-----MARTKQTARK
-----CCCCCHHHHH
40.95-
3Citrullination-----MARTKQTARK
-----CCCCCHHHHH
40.9516567635
3Methylation-----MARTKQTARK
-----CCCCCHHHHH
40.9518077460
4Phosphorylation----MARTKQTARKS
----CCCCCHHHHHC
20.2617938195
5Allysine---MARTKQTARKST
---CCCCCHHHHHCC
39.85-
5Acetylation---MARTKQTARKST
---CCCCCHHHHHCC
39.8516267050
5Crotonylation---MARTKQTARKST
---CCCCCHHHHHCC
39.8521925322
5Deamination---MARTKQTARKST
---CCCCCHHHHHCC
39.8527735137
5Methylation---MARTKQTARKST
---CCCCCHHHHHCC
39.8517194708
5Other---MARTKQTARKST
---CCCCCHHHHHCC
39.8527105115
6Formation of an isopeptide bond--MARTKQTARKSTG
--CCCCCHHHHHCCC
39.5232273471
6Serotonylation--MARTKQTARKSTG
--CCCCCHHHHHCCC
39.5230867594
7Phosphorylation-MARTKQTARKSTGG
-CCCCCHHHHHCCCC
29.9520228790
9CitrullinationARTKQTARKSTGGKA
CCCCHHHHHCCCCCC
36.52-
9CitrullinationARTKQTARKSTGGKA
CCCCHHHHHCCCCCC
36.5215345777
9MethylationARTKQTARKSTGGKA
CCCCHHHHHCCCCCC
36.528558401
10"N6,N6,N6-trimethyllysine"RTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.32-
10AcetylationRTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.3211242053
10ButyrylationRTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.3227105113
10CrotonylationRTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.3221925322
10LactoylationRTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.3231645732
10MethylationRTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.3211242053
10OtherRTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.3227105115
10UbiquitinationRTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.3222817900
11ADP-ribosylationTKQTARKSTGGKAPR
CCHHHHHCCCCCCCH
27.0828190768
11PhosphorylationTKQTARKSTGGKAPR
CCHHHHHCCCCCCCH
27.0810469656
12PhosphorylationKQTARKSTGGKAPRK
CHHHHHCCCCCCCHH
53.6526074081
15SumoylationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.47-
15AcetylationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.4717194708
15GlutarylationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.4731542297
15LactoylationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.47-
15MethylationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.47-
15OtherARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.4727105115
15SuccinylationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.4717194708
15SumoylationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.4717194708
15UbiquitinationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.4723000965
18Asymmetric dimethylarginineSTGGKAPRKQLATKA
CCCCCCCHHHHHHHH
44.18-
18CitrullinationSTGGKAPRKQLATKA
CCCCCCCHHHHHHHH
44.1816567635
18MethylationSTGGKAPRKQLATKA
CCCCCCCHHHHHHHH
44.1815345777
19N6-crotonyl-L-lysineTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.91-
19AcetylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9117194708
19ButyrylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9127105113
19CrotonylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9121925322
19GlutarylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9131542297
19LactoylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9131645732
19MethylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9117194708
19OtherTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9127105115
19SumoylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9117194708
19UbiquitinationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9123000965
24N6-crotonyl-L-lysinePRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.15-
242-HydroxyisobutyrylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.15-
24AcetylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1517194708
24ButyrylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1527105113
24CrotonylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1521925322
24GlutarylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1531542297
24LactoylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1531645732
24MethylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1516267050
24OtherPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1527105115
24SumoylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1517194708
24UbiquitinationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1523000965
27CitrullinationQLATKAARKSAPATG
HHHHHHHHHHCCCCC
38.02-
27CitrullinationQLATKAARKSAPATG
HHHHHHHHHHCCCCC
38.0216567635
28"N6,N6,N6-trimethyllysine"LATKAARKSAPATGG
HHHHHHHHHCCCCCC
46.36-
28AcetylationLATKAARKSAPATGG
HHHHHHHHHCCCCCC
46.3617194708
28CrotonylationLATKAARKSAPATGG
HHHHHHHHHCCCCCC
46.3621925322
28GlutarylationLATKAARKSAPATGG
HHHHHHHHHCCCCCC
46.3631542297
28LactoylationLATKAARKSAPATGG
HHHHHHHHHCCCCCC
46.3631645732
28MethylationLATKAARKSAPATGG
HHHHHHHHHCCCCCC
46.3617194708
28OtherLATKAARKSAPATGG
HHHHHHHHHCCCCCC
46.3627105115
28UbiquitinationLATKAARKSAPATGG
HHHHHHHHHCCCCCC
46.3623000965
29ADP-ribosylationATKAARKSAPATGGV
HHHHHHHHCCCCCCC
33.6528190768
29PhosphorylationATKAARKSAPATGGV
HHHHHHHHCCCCCCC
33.6523401153
33PhosphorylationARKSAPATGGVKKPH
HHHHCCCCCCCCCCC
33.1523403867
37"N6,N6,N6-trimethyllysine"APATGGVKKPHRYRP
CCCCCCCCCCCCCCC
64.95-
372-HydroxyisobutyrylationAPATGGVKKPHRYRP
CCCCCCCCCCCCCCC
64.95-
37AcetylationAPATGGVKKPHRYRP
CCCCCCCCCCCCCCC
64.9517194708
37MethylationAPATGGVKKPHRYRP
CCCCCCCCCCCCCCC
64.9517194708
37OtherAPATGGVKKPHRYRP
CCCCCCCCCCCCCCC
64.9524681537
37UbiquitinationAPATGGVKKPHRYRP
CCCCCCCCCCCCCCC
64.9523000965
38"N6,N6-dimethyllysine"PATGGVKKPHRYRPG
CCCCCCCCCCCCCCC
43.58-
38MethylationPATGGVKKPHRYRPG
CCCCCCCCCCCCCCC
43.58-
38UbiquitinationPATGGVKKPHRYRPG
CCCCCCCCCCCCCCC
43.5823000965
41DimethylationGGVKKPHRYRPGTVA
CCCCCCCCCCCCCHH
37.37-
41MethylationGGVKKPHRYRPGTVA
CCCCCCCCCCCCCHH
37.37-
42PhosphorylationGVKKPHRYRPGTVAL
CCCCCCCCCCCCHHH
20.3728152594
43MethylationVKKPHRYRPGTVALR
CCCCCCCCCCCHHHH
24.11-
46PhosphorylationPHRYRPGTVALREIR
CCCCCCCCHHHHHHH
12.8030266825
50MethylationRPGTVALREIRRYQK
CCCCHHHHHHHHHHH
27.79-
55PhosphorylationALREIRRYQKSTELL
HHHHHHHHHHCHHHH
15.5022817900
57"N6,N6,N6-trimethyllysine"REIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.87-
57AcetylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8717194708
57CrotonylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8721925322
57GlutarylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8731542297
57LactoylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.87-
57MethylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8717194708
57OtherREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8727105115
57SuccinylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8722389435
57SumoylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8722389435
57UbiquitinationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8727667366
58PhosphorylationEIRRYQKSTELLIRK
HHHHHHHCHHHHHHH
16.1623401153
59PhosphorylationIRRYQKSTELLIRKL
HHHHHHCHHHHHHHC
37.3730266825
64MethylationKSTELLIRKLPFQRL
HCHHHHHHHCCHHHH
34.13-
65MethylationSTELLIRKLPFQRLV
CHHHHHHHCCHHHHH
54.2216267050
65OtherSTELLIRKLPFQRLV
CHHHHHHHCCHHHHH
54.2224681537
80"N6,N6,N6-trimethyllysine"REIAQDFKTDLRFQS
HHHHHHHCCCHHHCH
49.79-
802-HydroxyisobutyrylationREIAQDFKTDLRFQS
HHHHHHHCCCHHHCH
49.79-
80AcetylationREIAQDFKTDLRFQS
HHHHHHHCCCHHHCH
49.7929211711
80GlutarylationREIAQDFKTDLRFQS
HHHHHHHCCCHHHCH
49.7931542297
80LactoylationREIAQDFKTDLRFQS
HHHHHHHCCCHHHCH
49.7931645732
80MethylationREIAQDFKTDLRFQS
HHHHHHHCCCHHHCH
49.7929211711
80OtherREIAQDFKTDLRFQS
HHHHHHHCCCHHHCH
49.7927105115
80SuccinylationREIAQDFKTDLRFQS
HHHHHHHCCCHHHCH
49.7929211711
80SumoylationREIAQDFKTDLRFQS
HHHHHHHCCCHHHCH
49.7929211711
80UbiquitinationREIAQDFKTDLRFQS
HHHHHHHCCCHHHCH
49.7927667366
81PhosphorylationEIAQDFKTDLRFQSS
HHHHHHCCCHHHCHH
40.0123401153
84MethylationQDFKTDLRFQSSAVM
HHHCCCHHHCHHHHH
30.30-
87PhosphorylationKTDLRFQSSAVMALQ
CCCHHHCHHHHHHHH
19.9723684312
88PhosphorylationTDLRFQSSAVMALQE
CCHHHCHHHHHHHHH
17.6928464451
97PhosphorylationVMALQEASEAYLVGL
HHHHHHHHHHHHHHH
23.2323684312
100PhosphorylationLQEASEAYLVGLFED
HHHHHHHHHHHHHCC
9.6223684312
108PhosphorylationLVGLFEDTNLCAIHA
HHHHHCCCCEEEEEE
23.9322817900
111S-palmitoylationLFEDTNLCAIHAKRV
HHCCCCEEEEEEEEC
3.4721076176
116AcetylationNLCAIHAKRVTIMPK
CEEEEEEEECEECHH
32.9919520870
116GlutarylationNLCAIHAKRVTIMPK
CEEEEEEEECEECHH
32.9931542297
116UbiquitinationNLCAIHAKRVTIMPK
CEEEEEEEECEECHH
32.99-
119PhosphorylationAIHAKRVTIMPKDIQ
EEEEEECEECHHHHH
18.6520068231
121SulfoxidationHAKRVTIMPKDIQLA
EEEECEECHHHHHHH
2.1728183972
123SumoylationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.51-
1232-HydroxyisobutyrylationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.51-
123AcetylationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5119520870
123GlutarylationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5131542297
123MethylationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5119520870
123OtherKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5127105115
123SuccinylationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5119520870
123SumoylationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5119520870
123UbiquitinationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5123000965
129MethylationPKDIQLARRIRGERA
HHHHHHHHHHHCCCC
43.05-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
4TPhosphorylationKinaseGSG2Q8TF76
GPS
7TPhosphorylationKinasePKC-FAMILY-GPS
7TPhosphorylationKinasePKC-Uniprot
11SPhosphorylationKinaseAURKBQ96GD4
GPS
11SPhosphorylationKinaseAURKCQ9UQB9
GPS
11SPhosphorylationKinaseRPS6KA3P51812
GPS
11SPhosphorylationKinaseRPS6KA4O75676
GPS
11SPhosphorylationKinaseRPS6KA5O75582
GPS
11SPhosphorylationKinaseALTERNATE-Uniprot
12TPhosphorylationKinasePKC-FAMILY-GPS
12TPhosphorylationKinasePKC-Uniprot
29SPhosphorylationKinaseAURKBQ96GD4
GPS
29SPhosphorylationKinaseAURKCQ9UQB9
GPS
29SPhosphorylationKinaseRPS6KA5O75582
GPS
29SPhosphorylationKinaseALTERNATE-Uniprot
46TPhosphorylationKinaseAKT1P31749
PSP
-KUbiquitinationE3 ubiquitin ligaseHUWE1Q7Z6Z7
PMID:22199232

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
3RMethylation

18077460
4TPhosphorylation

16267050
5Kubiquitylation

16267050
5KAcetylation

16267050
5KMethylation

18077460
5KMethylation

30867594
5KMethylation

16267050
5KMethylation

16267050
5KPhosphorylation

16267050
5KMethylation

16267050
5KMethylation

16267050
7TPhosphorylation

16267050
7TMethylation

16267050
9RMethylation

18077460
9RMethylation

16567635
9RMethylation

16267050
9RCitrullination

16567635
9RAcetylation

16267050
10KPhosphorylation

30257210
10KPhosphorylation

16267050
10KPhosphorylation

16267050
10KMethylation

16267050
10KMethylation

16267050
10KPhosphorylation

16267050
10KAcetylation

16267050
10KAcetylation

16267050
10KAcetylation

16267050
10KAcetylation

30257210
10KMethylation

16267050
10KMethylation

16267050
10KMethylation

16267050
10KMethylation

16267050
11SAcetylation

16267050
11SAcetylation

16267050
11SAcetylation

30257210
11SMethylation

16267050
11SMethylation

16267050
11SPhosphorylation

16267050
11SPhosphorylation

16267050
11SPhosphorylation

16267050
11SPhosphorylation

16267050
11SPhosphorylation

16267050
11SPhosphorylation

16267050
11SPhosphorylation

30257210
12TPhosphorylation

16267050
12TMethylation

16267050
12TPhosphorylation

16267050
18RCitrullination

16567635
18RAcetylation

16267050
18RMethylation

16267050
18RMethylation

18077460
18RMethylation

16567635
19KMethylation

16267050
19KAcetylation

16267050
24KMethylation

16267050
24KAcetylation

16267050
28KMethylation

16267050
28KMethylation

16267050
29SPhosphorylation

16267050
37KMethylation

16267050
57KMethylation

16267050
80KMethylation

16267050
80KMethylation

16267050
80KMethylation

16267050
80Kubiquitylation

16267050
80KSuccinylation

29211711
120Kubiquitylation

16267050
120KMethylation

16267050
123KSuccinylation

27436229
123KAcetylation

16267050

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of H32_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
KAT6A_HUMANKAT6Aphysical
20581860
PCNA_HUMANPCNAphysical
22387026
BAG6_HUMANBAG6physical
22373577
DOT1L_HUMANDOT1Lphysical
22373577
NRDC_HUMANNRD1physical
22294699
PHF2_HUMANPHF2physical
22294699
UHRF1_HUMANUHRF1physical
22294699
MTA1_HUMANMTA1physical
22294699
KAT5_HUMANKAT5physical
22081016
STAT1_HUMANSTAT1physical
21689637
JAK2_HUMANJAK2physical
21689637
INGR1_HUMANIFNGR1physical
21689637
BIRC5_HUMANBIRC5physical
20929775
BOREA_HUMANCDCA8physical
20929775
AURKB_HUMANAURKBphysical
20929775
INCE_HUMANINCENPphysical
20929775
SYUA_HUMANSNCAphysical
16959795
BRD7_HUMANBRD7physical
16265664

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of H32_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-28, AND MASS SPECTROMETRY.
"Identification of histone H3 lysine 36 acetylation as a highlyconserved histone modification.";
Morris S.A., Rao B., Garcia B.A., Hake S.B., Diaz R.L.,Shabanowitz J., Hunt D.F., Allis C.D., Lieb J.D., Strahl B.D.;
J. Biol. Chem. 282:7632-7640(2007).
Cited for: ACETYLATION AT LYS-37.
"Organismal differences in post-translational modifications inhistones H3 and H4.";
Garcia B.A., Hake S.B., Diaz R.L., Kauer M., Morris S.A., Recht J.,Shabanowitz J., Mishra N., Strahl B.D., Allis C.D., Hunt D.F.;
J. Biol. Chem. 282:7641-7655(2007).
Cited for: ACETYLATION AT LYS-5; LYS-10; LYS-15; LYS-19; LYS-24; LYS-28; LYS-37;LYS-57 AND LYS-80, METHYLATION AT LYS-5; LYS-10; LYS-19; LYS-24;LYS-28; LYS-37; LYS-57; LYS-65; LYS-80 AND LYS-123, AND MASSSPECTROMETRY.
"Coactivator-associated arginine methyltransferase-1 enhances nuclearfactor-kappaB-mediated gene transcription through methylation ofhistone H3 at arginine 17.";
Miao F., Li S., Chavez V., Lanting L., Natarajan R.;
Mol. Endocrinol. 20:1562-1573(2006).
Cited for: ACETYLATION AT LYS-10 AND LYS-15, METHYLATION AT ARG-18, ANDCITRULLINATION AT ARG-18.
"Quantitative proteomic analysis of post-translational modificationsof human histones.";
Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M.,Finn P., Grauslund M., Hansen A.M., Jensen O.N.;
Mol. Cell. Proteomics 5:1314-1325(2006).
Cited for: ACETYLATION AT LYS-10; LYS-15; LYS-19; LYS-24 AND LYS-28, METHYLATIONAT LYS-28; LYS-37 AND LYS-80, AND MASS SPECTROMETRY.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-10; LYS-15; LYS-19; LYS-24;LYS-28 AND LYS-37, AND MASS SPECTROMETRY.
"Expression patterns and post-translational modifications associatedwith mammalian histone H3 variants.";
Hake S.B., Garcia B.A., Duncan E.M., Kauer M., Dellaire G.,Shabanowitz J., Bazett-Jones D.P., Allis C.D., Hunt D.F.;
J. Biol. Chem. 281:559-568(2006).
Cited for: ACETYLATION AT LYS-10; LYS-15; LYS-19; LYS-24 AND LYS-28, METHYLATIONAT LYS-5; LYS-10; LYS-19; LYS-28; LYS-37; LYS-65; LYS-80 AND LYS-123,AND MASS SPECTROMETRY.
"Modifications of human histone H3 variants during mitosis.";
Garcia B.A., Barber C.M., Hake S.B., Ptak C., Turner F.B., Busby S.A.,Shabanowitz J., Moran R.G., Allis C.D., Hunt D.F.;
Biochemistry 44:13202-13213(2005).
Cited for: PROTEIN SEQUENCE OF 28-41, METHYLATION AT LYS-10; LYS-28 AND LYS-37,PHOSPHORYLATION AT THR-4; SER-11 AND SER-29, ACETYLATION AT LYS-10 ANDLYS-15, AND MASS SPECTROMETRY.
Methylation
ReferencePubMed
"Arginine methylation of the histone H3 tail impedes effectorbinding.";
Iberg A.N., Espejo A., Cheng D., Kim D., Michaud-Levesque J.,Richard S., Bedford M.T.;
J. Biol. Chem. 283:3006-3010(2008).
Cited for: METHYLATION AT ARG-3 BY PRMT6.
"Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex aremutually exclusive.";
Guccione E., Bassi C., Casadio F., Martinato F., Cesaroni M.,Schuchlautz H., Luescher B., Amati B.;
Nature 449:933-937(2007).
Cited for: METHYLATION AT ARG-3 BY PRMT6.
"PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4trimethylation.";
Hyllus D., Stein C., Schnabel K., Schiltz E., Imhof A., Dou Y.,Hsieh J., Bauer U.M.;
Genes Dev. 21:3369-3380(2007).
Cited for: METHYLATION AT ARG-3 BY PRMT6.
"Coactivator-associated arginine methyltransferase-1 enhances nuclearfactor-kappaB-mediated gene transcription through methylation ofhistone H3 at arginine 17.";
Miao F., Li S., Chavez V., Lanting L., Natarajan R.;
Mol. Endocrinol. 20:1562-1573(2006).
Cited for: ACETYLATION AT LYS-10 AND LYS-15, METHYLATION AT ARG-18, ANDCITRULLINATION AT ARG-18.
"Human PAD4 regulates histone arginine methylation levels viademethylimination.";
Wang Y., Wysocka J., Sayegh J., Lee Y.-H., Perlin J.R., Leonelli L.,Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y., Roeder R.G.,Clarke S., Stallcup M.R., Allis C.D., Coonrod S.A.;
Science 306:279-283(2004).
Cited for: CITRULLINATION AT ARG-9 AND ARG-18, AND METHYLATION AT ARG-18.
"Ligand-dependent activation of the farnesoid X-receptor directsarginine methylation of histone H3 by CARM1.";
Ananthanarayanan M., Li S., Balasubramaniyan N., Suchy F.J.,Walsh M.J.;
J. Biol. Chem. 279:54348-54357(2004).
Cited for: METHYLATION AT ARG-18.
"Histone H3 lysine 56 methylation regulates DNA replication throughits interaction wwith PCNA.";
Yu Y., Song C., Zhang Q., Dimaggio P.A., Garcia B.A., York A.,Carey M.F., Grunstein M.;
Mol. Cell 46:7-17(2012).
Cited for: METHYLATION AT LYS-57.
"Organismal differences in post-translational modifications inhistones H3 and H4.";
Garcia B.A., Hake S.B., Diaz R.L., Kauer M., Morris S.A., Recht J.,Shabanowitz J., Mishra N., Strahl B.D., Allis C.D., Hunt D.F.;
J. Biol. Chem. 282:7641-7655(2007).
Cited for: ACETYLATION AT LYS-5; LYS-10; LYS-15; LYS-19; LYS-24; LYS-28; LYS-37;LYS-57 AND LYS-80, METHYLATION AT LYS-5; LYS-10; LYS-19; LYS-24;LYS-28; LYS-37; LYS-57; LYS-65; LYS-80 AND LYS-123, AND MASSSPECTROMETRY.
"Quantitative proteomic analysis of post-translational modificationsof human histones.";
Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M.,Finn P., Grauslund M., Hansen A.M., Jensen O.N.;
Mol. Cell. Proteomics 5:1314-1325(2006).
Cited for: ACETYLATION AT LYS-10; LYS-15; LYS-19; LYS-24 AND LYS-28, METHYLATIONAT LYS-28; LYS-37 AND LYS-80, AND MASS SPECTROMETRY.
"Expression patterns and post-translational modifications associatedwith mammalian histone H3 variants.";
Hake S.B., Garcia B.A., Duncan E.M., Kauer M., Dellaire G.,Shabanowitz J., Bazett-Jones D.P., Allis C.D., Hunt D.F.;
J. Biol. Chem. 281:559-568(2006).
Cited for: ACETYLATION AT LYS-10; LYS-15; LYS-19; LYS-24 AND LYS-28, METHYLATIONAT LYS-5; LYS-10; LYS-19; LYS-28; LYS-37; LYS-65; LYS-80 AND LYS-123,AND MASS SPECTROMETRY.
"Methylation of histone H3 lysine 9 creates a binding site for HP1proteins.";
Lachner M., O'Carroll D., Rea S., Mechtler K., Jenuwein T.;
Nature 410:116-120(2001).
Cited for: METHYLATION AT LYS-10.
"Modifications of human histone H3 variants during mitosis.";
Garcia B.A., Barber C.M., Hake S.B., Ptak C., Turner F.B., Busby S.A.,Shabanowitz J., Moran R.G., Allis C.D., Hunt D.F.;
Biochemistry 44:13202-13213(2005).
Cited for: PROTEIN SEQUENCE OF 28-41, METHYLATION AT LYS-10; LYS-28 AND LYS-37,PHOSPHORYLATION AT THR-4; SER-11 AND SER-29, ACETYLATION AT LYS-10 ANDLYS-15, AND MASS SPECTROMETRY.
"Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strandbreaks.";
Huyen Y., Zgheib O., Ditullio R.A. Jr., Gorgoulis V.G., Zacharatos P.,Petty T.J., Sheston E.A., Mellert H.S., Stavridi E.S.,Halazonetis T.D.;
Nature 432:406-411(2004).
Cited for: METHYLATION AT LYS-80.
Phosphorylation
ReferencePubMed
"Quantitative interaction proteomics and genome-wide profiling ofepigenetic histone marks and their readers.";
Vermeulen M., Eberl H.C., Matarese F., Marks H., Denissov S.,Butter F., Lee K.K., Olsen J.V., Hyman A.A., Stunnenberg H.G.,Mann M.;
Cell 142:967-980(2010).
Cited for: PHOSPHORYLATION AT SER-58 AND THR-81.
"Phosphorylation of Ser28 in histone H3 mediated by mixed lineagekinase-like mitogen-activated protein triple kinase alpha.";
Choi H.S., Choi B.Y., Cho Y.-Y., Zhu F., Bode A.M., Dong Z.;
J. Biol. Chem. 280:13545-13553(2005).
Cited for: PHOSPHORYLATION AT SER-29.
"The kinase haspin is required for mitotic histone H3 Thr 3phosphorylation and normal metaphase chromosome alignment.";
Dai J., Sultan S., Taylor S.S., Higgins J.M.G.;
Genes Dev. 19:472-488(2005).
Cited for: PHOSPHORYLATION AT THR-4; SER-11 AND SER-29.
"Novel mitosis-specific phosphorylation of histone H3 at Thr11mediated by Dlk/ZIP kinase.";
Preuss U., Landsberg G., Scheidtmann K.H.;
Nucleic Acids Res. 31:878-885(2003).
Cited for: PHOSPHORYLATION AT SER-11 AND THR-12.
"Aurora-B phosphorylates Histone H3 at serine28 with regard to themitotic chromosome condensation.";
Goto H., Yasui Y., Nigg E.A., Inagaki M.;
Genes Cells 7:11-17(2002).
Cited for: PHOSPHORYLATION AT SER-11 AND SER-29.
"Identification of a novel phosphorylation site on histone H3 coupledwith mitotic chromosome condensation.";
Goto H., Tomono Y., Ajiro K., Kosako H., Fujita M., Sakurai M.,Okawa K., Iwamatsu A., Okigaki T., Takahashi T., Inagaki M.;
J. Biol. Chem. 274:25543-25549(1999).
Cited for: PROTEIN SEQUENCE OF 58-64; 117-120 AND 124-135, AND PHOSPHORYLATION ATSER-11 AND SER-29.
"Modifications of human histone H3 variants during mitosis.";
Garcia B.A., Barber C.M., Hake S.B., Ptak C., Turner F.B., Busby S.A.,Shabanowitz J., Moran R.G., Allis C.D., Hunt D.F.;
Biochemistry 44:13202-13213(2005).
Cited for: PROTEIN SEQUENCE OF 28-41, METHYLATION AT LYS-10; LYS-28 AND LYS-37,PHOSPHORYLATION AT THR-4; SER-11 AND SER-29, ACETYLATION AT LYS-10 ANDLYS-15, AND MASS SPECTROMETRY.
"Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylationat histone H3K4.";
Metzger E., Imhof A., Patel D., Kahl P., Hoffmeyer K., Friedrichs N.,Muller J.M., Greschik H., Kirfel J., Ji S., Kunowska N.,Beisenherz-Huss C., Gunther T., Buettner R., Schule R.;
Nature 464:792-796(2010).
Cited for: PHOSPHORYLATION AT THR-7.
"Phosphorylation of histone H3 at threonine 11 establishes a novelchromatin mark for transcriptional regulation.";
Metzger E., Yin N., Wissmann M., Kunowska N., Fischer K.,Friedrichs N., Patnaik D., Higgins J.M., Potier N., Scheidtmann K.H.,Buettner R., Schule R.;
Nat. Cell Biol. 10:53-60(2008).
Cited for: PHOSPHORYLATION AT THR-12.
"JAK2 phosphorylates histone H3Y41 and excludes HP1alpha fromchromatin.";
Dawson M.A., Bannister A.J., Gottgens B., Foster S.D., Bartke T.,Green A.R., Kouzarides T.;
Nature 461:819-822(2009).
Cited for: PHOSPHORYLATION AT TYR-42.

TOP